Icon

Offering Fact Sheet

应用于CROs的临床供应策略


药物研发申办方越来越多地寻求合同研究组织(CRO)来支持他们的临床研究,特别 是当这些研究是全球性的或较复杂的。为了提供成功的临床供应策略,在项目授予 前和授予后阶段,我们来探讨CRO合作时的关键供应考虑因素。

Learn more about:

Line

Why Catalent?

Catalyst + Talent

Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply over 70 billion doses of more than 7,000 products to over 1,000 customers annually. Catalent’s expert workforce exceeds 17,000, including more than 2,500 scientists and technicians. Headquartered in Somerset, New Jersey, the company generated $4 billion in revenue in its 2021 fiscal year. For more information, visit www.catalent.com.

More products. Better treatments. Reliably supplied.™